FDA Brief

Warning letters Drugs

FDA warning letter to

Atomix LLC

High riskIssued Dec 12, 2025Posted Dec 23, 2025Center for Drug Evaluation and Research (CDER)

FDA warned Atomix LLC that its website sells unapproved SARM drugs MK-2866 and RAD-140 as new drugs without approval.

What happened

In November 2025, FDA reviewed Atomix LLC's website and its Instagram and Facebook accounts. FDA found the company offered MK-2866 (Ostarine/Enobosarm) and RAD-140 (Testolone), marketed as SARMs, for sale in the United States. FDA said the products are unapproved new drugs and cited safety concerns including liver toxicity and increased risk of heart attack and stroke.

What FDA found

  1. FDA says the SARM products are unapproved new drugs because no FDA-approved application is in effect for them.

    FD&C Act section 505(a), 21 U.S.C. 355(a)
  2. FDA says introducing or delivering these products for interstate commerce violates the FD&C Act.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
  3. FDA says website and social media claims show the products are intended for human use as drugs, despite 'research use only' labeling.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128
  4. FDA says the products are new drugs not generally recognized as safe and effective for their labeled uses.

    FD&C Act section 201(p), 21 U.S.C. 321(p)

What FDA wants

FDA asks Atomix to notify it in writing within 15 working days of receipt of the steps taken to correct the violations and prevent recurrence, with supporting documents. If the company disputes the findings, it must include its reasoning and supporting information.

Who should pay attention

  • firms selling SARMs or research chemicals online
  • brands and marketers using social media to promote drug-like products
  • compliance teams for online supplement and drug sellers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk